{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T13:47:46Z","timestamp":1785764866268,"version":"3.56.0"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Schizophrenia Research"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.schres.2023.10.002","type":"journal-article","created":{"date-parts":[[2023,10,14]],"date-time":"2023-10-14T19:35:40Z","timestamp":1697312140000},"page":"21-24","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["A brief history and challenges of clozapine utilization in the Arab world"],"prefix":"10.1016","volume":"268","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2065-0476","authenticated-orcid":false,"given":"Monica","family":"Zolezzi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5110-784X","authenticated-orcid":false,"given":"Yassin","family":"Eltorki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.schres.2023.10.002_bb0005","article-title":"Utilization pattern of antipsychotics at a tertiary care hospital in Oman","volume":"17","author":"Al Za\u2019abi","year":"2014","journal-title":"Afr. J. Psychiatry (Johannesbg)"},{"key":"10.1016\/j.schres.2023.10.002_bb0010","doi-asserted-by":"crossref","first-page":"276","DOI":"10.4236\/ijcm.2012.34054","article-title":"Psychotropic drug prescribing trends in Bahrain: implications for sexual functions","volume":"3","author":"Al-Khaja","year":"2012","journal-title":"Int. J. Clin. Med."},{"key":"10.1016\/j.schres.2023.10.002_bb0015","first-page":"897","article-title":"Patterns of psychotropic medication use in inpatient and outpatient psychiatric settings in Saudi Arabia","volume":"12","author":"Alosaimi","year":"2016","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.schres.2023.10.002_bb0020","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/acps.12742","article-title":"International trends in clozapine use: a study in 17 countries","volume":"136","author":"Bachmann","year":"2017","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.schres.2023.10.002_bb0025","unstructured":"Clozapine REMS Program., n.d. What's new with clozapine: an overview. [WWW Document]. URL https:\/\/www.clozapinerems.com\/CpmgClozapineUI\/rems\/pdf\/WhatsNEWwithClozapine_An%20Overview.pdf (accessed 6.4.23)."},{"key":"10.1016\/j.schres.2023.10.002_bb0030","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1177\/0957154X07070335","article-title":"The history of clozapine and its emergence in the US market: a review and analysis","volume":"18","author":"Crilly","year":"2007","journal-title":"Hist. Psychiatry"},{"issue":"2","key":"10.1016\/j.schres.2023.10.002_bb0035","first-page":"73","article-title":"An international adult guideline for making clozapine titration safer by using six ancestry-based personalized dosing titrations, CRP, and clozapine levels","volume":"55","author":"de Leon","year":"2023","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.schres.2023.10.002_bb0040","doi-asserted-by":"crossref","DOI":"10.1176\/appi.ps.54.11.1453","article-title":"Psychopharmacology: underuse of evidence-based treatments in psychiatry","volume":"54","author":"Fayek","year":"2003","journal-title":"Psychiatr. Serv."},{"key":"10.1016\/j.schres.2023.10.002_bb0045","author":"Hale"},{"key":"10.1016\/j.schres.2023.10.002_bb0050","unstructured":"Hamad Medical Corporation (HMC), n.d. Clozapine prescribing guidelines [WWW document]. HMC intranet. URL https:\/\/itawasol\/EN\/How%20We%20Work\/Clinical-Guidelines\/Clinical%20Guidelines\/Clozapine%20Clinical%20Practice%20Guideline%20-%20Final%209apr2019.pdf#search=clozapine. (accessed 6.4.23)."},{"key":"10.1016\/j.schres.2023.10.002_bb0055","doi-asserted-by":"crossref","DOI":"10.1186\/s12888-022-03910-6","article-title":"Factors predicting serum clozapine levels in middle eastern patients: an observational study","volume":"22","author":"Hassab Errasoul","year":"2022","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.schres.2023.10.002_bb0060","first-page":"8254","article-title":"A historical perspective of clozapine","volume":"60","author":"Hippius","year":"1999","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.schres.2023.10.002_bb0065","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1211\/146080899128735108","article-title":"Steady-state pharmacokinetics of clozapine in refractory schizophrenic Saudi Arabian patients","volume":"5","author":"Hussein","year":"1999","journal-title":"Pharm. Pharmacol. Commun."},{"key":"10.1016\/j.schres.2023.10.002_bb0070","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S0140-6736(75)90206-8","article-title":"Letter: clozapine and agranulocytosis","volume":"2","author":"Id\u00e4np\u00e4\u00e4n-Heikkil\u00e4","year":"1975","journal-title":"Lancet"},{"key":"10.1016\/j.schres.2023.10.002_bb0075","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ajp.2018.12.011","article-title":"A qualitative exploration of clozapine prescribing and monitoring practices in the Arabian Gulf countries","volume":"39","author":"Ismail","year":"2019","journal-title":"Asian J. Psychiatr."},{"key":"10.1016\/j.schres.2023.10.002_bb0080","first-page":"62","article-title":"Clozapine in treatment-resistant schizophrenics - PubMed","volume":"24","author":"Kane","year":"1988","journal-title":"Psychopharmacol. Bull."},{"key":"10.1016\/j.schres.2023.10.002_bb0085","unstructured":"Kelly, D.L., Kreyenbuhl, J., Buchanan, R.W., Malhotra, A.K., n.d. Why Not Clozapine?."},{"key":"10.1016\/j.schres.2023.10.002_bb0090","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1007\/s40263-021-00847-4","article-title":"Absolute and dose-adjusted serum concentrations of clozapine in patients switching vs. maintaining treatment: an observational study of 1979 patients","volume":"35","author":"Kylles\u00f8","year":"2021","journal-title":"CNS Drugs"},{"key":"10.1016\/j.schres.2023.10.002_bb0095","unstructured":"Leponex\u00ae Clozapine [WWW Document], n.d.. Saudi Food and Drug Authority. URL https:\/\/www.sfda.gov.sa\/en\/node\/78779 (accessed 6.6.23)."},{"key":"10.1016\/j.schres.2023.10.002_bb0100","first-page":"40","article-title":"A comprehensive monitoring of clozapine and related components in clinical practices. Saudi Arabian scenario","volume":"51","author":"Lucca","year":"2021","journal-title":"Psychopharmacol. Bull."},{"key":"10.1016\/j.schres.2023.10.002_bb0105","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1080\/17425255.2021.1974400","article-title":"Therapeutic drug monitoring of clozapine in adults with schizophrenia: a review of challenges and strategies","volume":"17","author":"Molden","year":"2021","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.schres.2023.10.002_bb0115","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s40263-016-0311-1","article-title":"Worldwide differences in regulations of clozapine use","volume":"30","author":"Nielsen","year":"2016","journal-title":"CNS Drugs"},{"key":"10.1016\/j.schres.2023.10.002_bb0120","doi-asserted-by":"crossref","DOI":"10.1017\/S204579602200066X","article-title":"Clozapine haematological monitoring for neutropenia: a global perspective","volume":"31","author":"Oloyede","year":"2022","journal-title":"Epidemiol. Psychiatr. Sci."},{"key":"10.1016\/j.schres.2023.10.002_bb0125","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1192\/bjp.bp.112.114777","article-title":"Clinician hesitation prior to clozapine initiation: is it justifiable?","volume":"201","author":"Patel","year":"2012","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.schres.2023.10.002_bb9000","doi-asserted-by":"crossref","first-page":"e406","DOI":"10.1097\/MJT.0000000000000894","article-title":"Off-label use of clozapine in children and adolescents-A literature review","volume":"26","author":"Rachamallu","year":"2019","journal-title":"Am. J. Ther."},{"key":"10.1016\/j.schres.2023.10.002_bb0130","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.jsps.2022.12.005","article-title":"Patients' and primary carers' views on clozapine treatment for schizophrenia: a cross-sectional study in Qatar","volume":"31","author":"Srour","year":"2023","journal-title":"Saudi Pharm. J."},{"key":"10.1016\/j.schres.2023.10.002_bb0135","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1176\/appi.ps.201300180","article-title":"Geographic and clinical variation in clozapine use in the United States","volume":"65","author":"Stroup","year":"2014","journal-title":"Psychiatr. Serv."},{"key":"10.1016\/j.schres.2023.10.002_bb9005","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1007\/s40262-023-01247-1","article-title":"Association between clozapine plasma concentrations and treatment response: A systematic review, meta-analysis and individual participant data meta-analysis","volume":"62","author":"Tralongo","year":"2023","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.schres.2023.10.002_bb0140","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1177\/2045125314566808","article-title":"Clozapine prescribing in the UK: views and experience of consultant psychiatrists","volume":"5","author":"Tungaraza","year":"2015","journal-title":"Ther. Adv. Psychopharmacol."},{"key":"10.1016\/j.schres.2023.10.002_bb0145","series-title":"FDA Drug Safety Communication: FDA Modifies Monitoring for Neutropenia Associated With Schizophrenia Medicine Clozapine; Approves New Shared REMS Program for All Clozapine Medicines Safety Announcement","author":"United States Food and Drug Administration (FDA)","year":"2015"},{"key":"10.1016\/j.schres.2023.10.002_bb0150","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.2617","article-title":"Clozapine prescribing practice and trends in Qatar: first national observational study","volume":"12","author":"Wadoo","year":"2022","journal-title":"Brain Behav."},{"key":"10.1016\/j.schres.2023.10.002_bb0155","doi-asserted-by":"crossref","DOI":"10.1186\/1471-244X-14-102","article-title":"Clozapine: a review of clinical practice guidelines and prescribing trends","volume":"14","author":"Warnez","year":"2014","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.schres.2023.10.002_bb0160","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1345\/aph.1K662","article-title":"Treatment pathway and patterns of clozapine prescribing for schizophrenia in New Zealand","volume":"42","author":"Wheeler","year":"2008","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.schres.2023.10.002_bb0165","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/j.1365-2753.2008.01032.x","article-title":"Impact of audit and feedback on antipsychotic prescribing in schizophrenia","volume":"15","author":"Wheeler","year":"2009","journal-title":"J. Eval. Clin. Pract."},{"key":"10.1016\/j.schres.2023.10.002_bb0170","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1177\/0020764018789200","article-title":"Stigma associated with mental illness and its treatment in the Arab culture: a systematic review","volume":"64","author":"Zolezzi","year":"2018","journal-title":"Int. J. Soc. Psychiatry"},{"key":"10.1016\/j.schres.2023.10.002_bb0175","article-title":"A guideline review on treatment-resistant schizophrenia: a focus on clozapine and other pharmacotherapeutic strategies","volume":"7","author":"Zolezzi","year":"2021","journal-title":"Austin J. Psychiatry Behav. Sci."}],"container-title":["Schizophrenia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996423003559?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996423003559?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,11]],"date-time":"2024-06-11T10:26:16Z","timestamp":1718101576000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920996423003559"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":36,"alternative-id":["S0920996423003559"],"URL":"https:\/\/doi.org\/10.1016\/j.schres.2023.10.002","relation":{},"ISSN":["0920-9964"],"issn-type":[{"value":"0920-9964","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A brief history and challenges of clozapine utilization in the Arab world","name":"articletitle","label":"Article Title"},{"value":"Schizophrenia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.schres.2023.10.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}